Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults.
Vaccines (Basel)
; 9(4)2021 Apr 16.
Article
in En
| MEDLINE
| ID: mdl-33923628
Full text:
1
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Year:
2021
Type:
Article